iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
116.3 ^USD	+2.39%		+5.91%	+8.69%

Mar. 08	IRhythm Technologies Closes $661 Million Notes Offering	MT
Mar. 05	Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing	MT

Irhythm Technologies, Inc. Provides Earnings Guidance for the First Quarter of 2021

February 25, 2021 at 04:05 pm EST

iRhythm Technologies, Inc. projects revenue for the first quarter 2021. For the first quarter of 2021, the company expects volume growth of 5% over the fourth quarter of 2020 and operating expenses to range from $77 million to $79 million.

Latest news about iRhythm Technologies, Inc.

IRhythm Technologies Closes $661 Million Notes Offering	Mar. 08	MT
Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing	Mar. 05	MT
IRhythm Technologies Prices $575 Million Convertible Notes Offering	Mar. 05	MT
IRhythm Shares Fall After Firm Plans $450 Million Convertible Notes Offering	Mar. 04	MT
IRhythm Technologies Plans to Offer $450 in Convertible Notes Due 2029	Mar. 04	MT
Needham Adjusts iRhythm Technologies' Price Target to $137 From $136, Keeps Buy Rating	Feb. 23	MT
IRhythm Technologies Q4 Adjusted Loss Widens, Revenue Rises; 2024 Sales Outlook Set -- Shares Slump After Hours	Feb. 22	MT
Transcript : IRhythm Technologies, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
IRhythm Technologies, Inc. Provides Earnings Guidance for the Year 2024	Feb. 22	CI
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Transcript : IRhythm Technologies, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM	Jan. 08
IRhythm Technologies Closes $150 Million Debt Facility; 2024 Revenue Forecast Issued	Jan. 08	MT
Needham Raises iRhythm Technologies' Price Target to $136 From $108, Keeps Buy Rating	Jan. 08	MT
Irhythm Technologies, Inc. Entered into A Credit, Security and Guaranty Agreement with Braidwell Transaction Holdings LLC	Jan. 08	CI
IRhythm Technologies, Inc. Revises Revenue Guidance for the Year 2024	Jan. 08	CI
IRhythm Technologies Says Study Shows Zio Has 'Higher Diagnostic Yield' Compared With Other Cardiac Monitors	Jan. 05	MT
IRhythm , Inc. Announces Results from the Cardiac Ambulatory Monitor EvaLuation of Outcomes and Time to Events	Jan. 05	CI
Irhythm Technologies Insider Sold Shares Worth $745,692, According to a Recent SEC Filing	Jan. 04	MT
IRhythm Technologies Says it Obtained EU CE Mark for Zio Monitor, Zeus System	Jan. 03	MT
Truist Securities Adjusts iRhythm Technologies Price Target to $115 From $100, Maintains Buy Rating	Dec. 12	MT
North American Morning Briefing : Traders Eye -2-	Dec. 12	DJ
Citigroup Upgrades iRhythm Technologies to Buy From Neutral, Raises Price Target to $110 From $85	Dec. 11	MT
Transcript : IRhythm Technologies, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Earnings Flash (IRTC) IRHYTHM Posts Q3 Revenue $124.6M, vs. Street Est of $122.6M	Nov. 02	MT

Chart iRhythm Technologies, Inc.

Duration

Period

More charts

Company Profile

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-02 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company